The 3D bioprinting market size is projected to reach $792.5 million by 2022.

3D Bioprinting Market is driven by high demand of tissues and organs for transplantation across the globe.

The market is driven by factors, such as technological advancements and innovations, increasing compliance for drug discovery processes, and high demand for organ and tissue transplantation.

In terms of technology, the 3D bioprinting market has been segmented into syringe based 3D bioprinting, pneumatic extrusion based 3D bioprinting, inkjet based 3D bioprinting, laser based 3D bioprinting and others. The syringe based 3D bioprinting was the most commonly used bioprinting technology; whereas, pneumatic extrusion based 3D bioprinting is expected to witness the fastest growth during the foreast period.

More News